SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-261704
Filing Date
2019-10-03
Accepted
2019-10-03 16:48:59
Documents
3
Period of Report
2019-10-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d814327d8k.htm 8-K 20655
2 EX-99.1 d814327dex991.htm EX-99.1 20168
3 GRAPHIC g814327g1002215053051.jpg GRAPHIC 2623
  Complete submission text file 0001193125-19-261704.txt   45922
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 191136329
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences